SAWYER JAMES S 4
4 · PRAXAIR INC · Filed Apr 30, 2013
Insider Transaction Report
Form 4
SAWYER JAMES S
Executive V.P. and CFO
Transactions
- Sale
Common Stock
2013-04-26$112.85/sh−38,099$4,299,556→ 20,804 total
Holdings
- 12,940.155(indirect: By 401(k))
Common Stock
- 27,067
Stock Option (right to buy)
Exercise: $60.92From: 2010-02-24Exp: 2019-02-24→ Common Stock (27,067 underlying) - 53,755
Stock Option (right to buy)
Exercise: $109.68From: 2013-02-28Exp: 2022-02-28→ Common Stock (53,755 underlying) - 5,260.84
Deferred Stock
Exercise: $0.00→ Common Stock (5,260.84 underlying) - 35,814
Stock Option (right to buy)
Exercise: $76.16From: 2011-02-23Exp: 2020-02-23→ Common Stock (35,814 underlying) - 37,447
Stock Option (right to buy)
Exercise: $83.89From: 2009-02-26Exp: 2018-02-26→ Common Stock (37,447 underlying) - 56,070
Stock Option (right to buy)
Exercise: $97.84From: 2012-02-22Exp: 2021-02-22→ Common Stock (56,070 underlying) - 43,720
Stock Option (right to buy)
Exercise: $110.58From: 2014-02-26Exp: 2023-02-26→ Common Stock (43,720 underlying)
Footnotes (7)
- [F1]The $112.8522 price reported is the weighted average sale price. The sale prices ranged from $112.535 to $113.15 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number os shares sold at each separate price.
- [F2]This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- [F3]This option vests over three years in three consecutive equal annual installments beginning on February 22, 2012.
- [F4]This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
- [F5]This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
- [F6]Conversion to Praxair Common Stock is on a 1-for-1 basis.
- [F7]Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.